LAKE OSWEGO, Ore., Feb. 28, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark Schwartz, Ph.D., will provide a presentation entitled, "New Horizons in Active Cancer Immunotherapy: Developing Cancer Vaccines" at the Cancer Targets and Therapeutics Conference. The presentation will take place on Tuesday, February 28, 2012 at 8:00 AM PST at the Red Rock Resort and Casino in Las Vegas, Nevada.
About Galena Biopharma
Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com.
The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647